Profile
Eduardo G.
Abrao has been Vice President-Clinical Development and Chief Medical Officer for Noven Pharmaceuticals, Inc. since September 2003.
From March 2002 to October 2002, he was Vice President-Regulatory Affairs and Drug Safety of Berlex Laboratories, Inc. From 1996 to 2002, he held various regulatory and operational positions at Otsuka America Pharmaceutical, Inc., most recently as President and Chief Operating Officer.
From 1989 to 1996, Dr. Abrao was Vice President of the International Medical Department for Marion Merrell Dow/Hoechst Marion Roussel.
Former positions of Eduardo G. Abrao
| Companies | Position | End |
|---|---|---|
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Chief Tech/Sci/R&D Officer | 2007-12-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
- Stock Market
- Insiders
- Eduardo G. Abrao
